• Alarming Levels of Drug-Resistant Tuberculosis in HIV-Infected Patients in Metropolitan Mumbai, India

      Isaakidis, P; Das, M; Kumar, A M V; Peskett, C; Khetarpal, M; Bamne, A; Adsul, B; Manglani, M; Sachdeva, K S; Parmar, M; et al. (Public Library of Science, 2014-10-21)
      Drug-resistant tuberculosis (DR-TB) is a looming threat to tuberculosis control in India. However, no countrywide prevalence data are available. The burden of DR-TB in HIV-co-infected patients is likewise unknown. Undiagnosed and untreated DR-TB among HIV-infected patients is a major cause of mortality and morbidity. We aimed to assess the prevalence of DR-TB (defined as resistance to any anti-TB drug) in patients attending public antiretroviral treatment (ART) centers in greater metropolitan Mumbai, India.
    • Impact of Introducing the Line Probe Assay on Time to Treatment Initiation of MDR-TB in Delhi, India

      Singla, N; Satyanarayana, S; Sachdeva, K S; Van den Bergh, R; Reid, T; Tayler-Smith, K; Myneedu, V P; Ali, E; Enarson, D A; Behera, D; et al. (Public Library of Science, 2014-07-24)
      National Institute of Tuberculosis and Respiratory Diseases (erstwhile Lala Ram Sarup Institute) in Delhi, India.